Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debby Bogaert

Showing results (111-120 of 143) with videos related to

Pageof 15
Sort By:
Nature Communications|July 7, 2019
Interaction between the nasal microbiota and S. pneumoniae in the context of live-attenuated influenza vaccineWouter A A de Steenhuijsen Piters, Simon P Jochems, Elena Mitsi, et al.
Clinical & Translational Immunology|November 8, 2021
A novel method to standardise serum IgA measurements shows an increased prevalence of IgA deficiency in young children with recurrent respiratory tract infectionsMischa H Koenen, Madeleen Bosma, Udo A Roorda, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Integrative Mapping of Pre-existing Immune Landscapes for Vaccine Response PredictionStephanie Hao, Ivan Tomic, Benjamin B Lindsey, et al.
The Journal of Clinical Investigation|July 15, 2025
Integrative mapping of pre-existing influenza immune landscapes predicts vaccine responseStephanie Hao, Ivan Tomic, Benjamin B Lindsey, et al.
STAR Protocols|April 8, 2025
Protocol for microbial profiling of low-biomass upper respiratory tract samplesMari-Lee Odendaal, Mei Ling J N Chu, Kayleigh Arp, et al.
Journal of Personalized Medicine|April 30, 2021
Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a S1251N MutationMaartje I Kristensen, Karin M de Winter-de Groot, Gitte Berkers, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 4, 2020
Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatmentMaartje Kristensen, Sabine M P J Prevaes, Gino Kalkman, et al.
Plos One|October 20, 2012
Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteriaMenno R van den Bergh, Giske Biesbroek, John W A Rossen, et al.
The Lancet. Microbe|December 9, 2021
The effect of live attenuated influenza vaccine on pneumococcal colonisation densities among children aged 24-59 months in The Gambia: a phase 4, open label, randomised, controlled trialChikondi Peno, Edwin P Armitage, Melanie Clerc, et al.
BMJ Open|December 17, 2021
Topical or oral antibiotics for children with acute otitis media presenting with ear discharge: study protocol of a randomised controlled non-inferiority trialSaskia Hullegie, Roderick P Venekamp, Thijs M A van Dongen, et al.
Pageof 15

Showing results (111-120 of 143) with videos related to

Sort By:
Pageof 15
Nature Communications|July 7, 2019
Interaction between the nasal microbiota and S. pneumoniae in the context of live-attenuated influenza vaccineWouter A A de Steenhuijsen Piters, Simon P Jochems, Elena Mitsi, et al.
Clinical & Translational Immunology|November 8, 2021
A novel method to standardise serum IgA measurements shows an increased prevalence of IgA deficiency in young children with recurrent respiratory tract infectionsMischa H Koenen, Madeleen Bosma, Udo A Roorda, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Integrative Mapping of Pre-existing Immune Landscapes for Vaccine Response PredictionStephanie Hao, Ivan Tomic, Benjamin B Lindsey, et al.
The Journal of Clinical Investigation|July 15, 2025
Integrative mapping of pre-existing influenza immune landscapes predicts vaccine responseStephanie Hao, Ivan Tomic, Benjamin B Lindsey, et al.
STAR Protocols|April 8, 2025
Protocol for microbial profiling of low-biomass upper respiratory tract samplesMari-Lee Odendaal, Mei Ling J N Chu, Kayleigh Arp, et al.
Journal of Personalized Medicine|April 30, 2021
Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a S1251N MutationMaartje I Kristensen, Karin M de Winter-de Groot, Gitte Berkers, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 4, 2020
Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatmentMaartje Kristensen, Sabine M P J Prevaes, Gino Kalkman, et al.
Plos One|October 20, 2012
Associations between pathogens in the upper respiratory tract of young children: interplay between viruses and bacteriaMenno R van den Bergh, Giske Biesbroek, John W A Rossen, et al.
The Lancet. Microbe|December 9, 2021
The effect of live attenuated influenza vaccine on pneumococcal colonisation densities among children aged 24-59 months in The Gambia: a phase 4, open label, randomised, controlled trialChikondi Peno, Edwin P Armitage, Melanie Clerc, et al.
BMJ Open|December 17, 2021
Topical or oral antibiotics for children with acute otitis media presenting with ear discharge: study protocol of a randomised controlled non-inferiority trialSaskia Hullegie, Roderick P Venekamp, Thijs M A van Dongen, et al.
Pageof 15